Ulf has been a director of Isofol since 2010 and has been its clinical and regulatory expert. He has a…
Tony Gustavsson leads the licensing and commercialization efforts of the company’s lead drug candidate arfolitixorin. Prior to joining Isofol, Mr.…
Dr. Roger Tell is responsible for medical and scientific issues at Isofol. Dr. Tell joined Isofol in February 2019 and…
Gustaf is a business-oriented economist with broad financial and operational experience. He is responsible for the company’s financial management and…
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.